Skip to main content
Tuoxin Pharmaceutical Group Co.,Ltd. logo

Tuoxin Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 301089 ISIN · CNE100004YC3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 734 across all filing types
Latest filing 2024-08-23 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 301089

About Tuoxin Pharmaceutical Group Co.,Ltd.

https://www.tuoxinpharm.com

Tuoxin Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and distribution of nucleosides and nucleotides. The company serves as a major global supplier of active pharmaceutical ingredients (APIs) and chemical intermediates. Its core product portfolio includes cytidine, inosine, guanosine, adenosine, and their various derivatives, which are essential components in the synthesis of antiviral, anti-tumor, and cardiovascular medications. Notably, the group provides key intermediates for drugs such as Ribavirin and Azvudine. Tuoxin Pharmaceutical leverages advanced synthetic biotechnology and large-scale manufacturing capabilities to support the global pharmaceutical industry. The company maintains a focus on technological innovation and quality control to ensure the stability and purity of its chemical products for diverse therapeutic applications.

Recent filings

Filing Released Lang Actions
关于2024年半年度募集资金存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the storage and usage of funds raised by the company during the first half of 2024. It references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange, discusses the amounts raised, usage of funds, changes in investment projects, and compliance with regulatory requirements. The document includes financial figures, project progress, and detailed explanations of fund management and usage. It is a specialized report focusing on the management and use of raised capital, not a general financial report or earnings release. This matches the description of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital usage. The document length and detail confirm it is the report itself, not just an announcement or certification. Therefore, the appropriate classification is CAP with high confidence.
2024-08-23 Chinese
2024年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2024年半年度报告摘要' which translates to '2024 Semi-Annual Report Summary'. It contains detailed financial data such as revenue, net profit, earnings per share, total assets, and shareholder information for the half-year period. The document is about 3961 characters long, which is relatively short but contains substantive financial data and analysis, not just an announcement or a link to a report. It is a summary of the half-year financial report, which fits the definition of an Interim / Quarterly Report (IR). There is no indication that this is merely an announcement or a certification, and it includes actual financial figures and analysis for the half-year period. Therefore, the correct classification is IR (Interim / Quarterly Report). H1 2024
2024-08-23 Chinese
2023年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is an announcement regarding the implementation of the 2023 annual equity distribution (dividend) plan approved at the 2023 Annual General Meeting. It details the dividend amount per share, the record date, the ex-dividend date, and the method of dividend distribution. It also references the shareholder meeting resolutions and related documents. The document is short (1796 characters) and serves as a formal notice of dividend distribution rather than a full financial report or annual report. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2024-05-15 Chinese
关于董事会、监事会完成换届选举及聘任高级管理人员、证券事务代表的公告
Board/Management Information Classification · 100% confidence The document is an announcement from a company about the completion of the board of directors and supervisory board re-election, as well as the appointment of senior management and securities affairs representatives. It details the composition of the new board, committees, supervisory board, and senior management personnel, including their qualifications and resumes. There is no financial data, earnings information, or report publication mentioned. The content focuses on management and board changes, which fits the category of Board/Management Information (MANG). The document length is over 5,000 characters and contains detailed information about management appointments and board composition, confirming it is not a brief announcement or a report publication notice.
2024-05-13 Chinese
北京市康达律师事务所关于拓新药业集团股份有限公司2023年年度股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the 2023 Annual General Meeting (AGM) of a company. It details the procedures for convening and holding the AGM, the qualifications of attendees, the voting procedures, and the voting results on various agenda items including approval of the 2023 annual report, financial statements, profit distribution plan, director elections, and other corporate matters. The document is dated May 13, 2024, and explicitly references the 2023 Annual General Meeting. It does not contain the actual annual report or financial statements but rather legal verification and validation of the AGM process and voting outcomes. This type of document is typically classified as Declaration of Voting Results & Voting Rights Announcements (DVA) because it reports the official voting results from the shareholder meeting. The document length is over 10,000 characters and contains detailed voting results, not just a brief announcement or a report publication notice, so it is not RPA or RNS. It is not a management report, earnings release, or board/management change announcement. Therefore, the best fitting classification is DVA with high confidence.
2024-05-13 Chinese
第五届董事会第一次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of the resolutions passed at the first meeting of the fifth board of directors of the company. It details the election and appointment of key board and senior management positions such as chairman, general manager, deputy general managers, financial officer, board secretary, and committee members. The document includes voting results and references compliance with company law and stock exchange regulations. There is no financial data, earnings information, or report publication mentioned. The content clearly relates to changes and appointments in the company's board and senior management. Therefore, this document fits the category of Board/Management Information (MANG). The document length is 2432 characters, which is consistent with a detailed announcement rather than a full report or a brief notice.
2024-05-13 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.